Furthermore, treatment of the DKC1 inhibitor pyrazofurin (PF)[22] significantly decreased the total RNA pseudouridine content and the growth of DLD‐1 and HCT116 cells (Figure 2H) and the formation of human CRC organoids (Figure 2I). Here, DKC1 is linked to colorectal carcinoma.